WO2005111121A3 - Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine - Google Patents

Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine Download PDF

Info

Publication number
WO2005111121A3
WO2005111121A3 PCT/EP2005/005174 EP2005005174W WO2005111121A3 WO 2005111121 A3 WO2005111121 A3 WO 2005111121A3 EP 2005005174 W EP2005005174 W EP 2005005174W WO 2005111121 A3 WO2005111121 A3 WO 2005111121A3
Authority
WO
WIPO (PCT)
Prior art keywords
gelatine
bodies made
shaped bodies
producing shaped
crosslinked
Prior art date
Application number
PCT/EP2005/005174
Other languages
English (en)
French (fr)
Other versions
WO2005111121A2 (de
Inventor
Michael Ahlers
Original Assignee
Gelita Ag
Michael Ahlers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag, Michael Ahlers filed Critical Gelita Ag
Priority to EP05745724A priority Critical patent/EP1747247A2/de
Priority to AU2005243474A priority patent/AU2005243474A1/en
Priority to JP2007512103A priority patent/JP2007537314A/ja
Priority to EA200602031A priority patent/EA200602031A1/ru
Priority to CA002558351A priority patent/CA2558351A1/en
Priority to BRPI0510782-2A priority patent/BRPI0510782A/pt
Publication of WO2005111121A2 publication Critical patent/WO2005111121A2/de
Publication of WO2005111121A3 publication Critical patent/WO2005111121A3/de
Priority to US11/555,295 priority patent/US20070077274A1/en
Priority to NO20065652A priority patent/NO20065652L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/244—Stepwise homogeneous crosslinking of one polymer with one crosslinking system, e.g. partial curing
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/30—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by mixing gases into liquid compositions or plastisols, e.g. frothing with air
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/36—After-treatment
    • C08J9/38—Destruction of cell membranes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/02—Foams characterised by the foaming process characterised by mechanical pre- or post-treatments
    • C08J2201/024—Preparation or use of a blowing agent concentrate, i.e. masterbatch in a foamable composition
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00—Foams characterised by their intended use
    • C08J2207/10—Medical applications, e.g. biocompatible scaffolds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof
    • C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0016—Plasticisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0025—Crosslinking or vulcanising agents; including accelerators
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates
    • C08K5/053—Polyhydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Polymers & Plastics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)

Abstract

Um ein Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine zur Verfügung zu stellen, welche als Trägermaterial für Gewebeim­plantate eingesetzt werden können und eine individuell einstellbare Abbauzeit aufweisen, wird vorgeschlagen, dass dieses Verfahren folgende Schritte um­fasst: a) Herstellen einer wässrigen Gelatinelösung; b) partielles Vernetzen der gelösten Gelatine; c) Herstellen eines Formkörpers ausgehend von der Gelatinelösung mit der partiell vernetzten Gelatine; und d) Vernetzen der im Formkörper enthaltenen Gelatine.
PCT/EP2005/005174 2004-05-12 2005-05-12 Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine WO2005111121A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP05745724A EP1747247A2 (de) 2004-05-12 2005-05-12 Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine
AU2005243474A AU2005243474A1 (en) 2004-05-12 2005-05-12 Method for producing shaped bodies made from crosslinked gelatine
JP2007512103A JP2007537314A (ja) 2004-05-12 2005-05-12 架橋したゼラチンを基にした造形体の製造法
EA200602031A EA200602031A1 (ru) 2004-05-12 2005-05-12 Способ изготовления формованных изделий на основе сшитого желатина
CA002558351A CA2558351A1 (en) 2004-05-12 2005-05-12 Method for producing shaped bodies made from crosslinked gelatine
BRPI0510782-2A BRPI0510782A (pt) 2004-05-12 2005-05-12 processo para a produção de artigos moldados à base de gelatinas reticuladas
US11/555,295 US20070077274A1 (en) 2004-05-12 2006-11-01 Method for producing shaped bodies based on crosslinked gelatine
NO20065652A NO20065652L (no) 2004-05-12 2006-12-07 Fremgangsmate for fremstilling av formede gjenstander pa basis av tverrbundet gelatin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024635.1 2004-05-12
DE102004024635A DE102004024635A1 (de) 2004-05-12 2004-05-12 Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/555,295 Continuation-In-Part US20070077274A1 (en) 2004-05-12 2006-11-01 Method for producing shaped bodies based on crosslinked gelatine

Publications (2)

Publication Number Publication Date
WO2005111121A2 WO2005111121A2 (de) 2005-11-24
WO2005111121A3 true WO2005111121A3 (de) 2006-03-02

Family

ID=35058421

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/005174 WO2005111121A2 (de) 2004-05-12 2005-05-12 Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine

Country Status (13)

Country Link
US (1) US20070077274A1 (de)
EP (1) EP1747247A2 (de)
JP (1) JP2007537314A (de)
AU (1) AU2005243474A1 (de)
BR (1) BRPI0510782A (de)
CA (1) CA2558351A1 (de)
CR (1) CR8427A (de)
DE (1) DE102004024635A1 (de)
EA (1) EA200602031A1 (de)
EC (1) ECSP066989A (de)
NO (1) NO20065652L (de)
WO (1) WO2005111121A2 (de)
ZA (1) ZA200609115B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4917775B2 (ja) * 2005-08-05 2012-04-18 グンゼ株式会社 癒着防止膜の製造方法
DE102005054940A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Verbundmaterial, insbesondere für die medizinische Anwendung , und Verfahren zu dessen Herstellung
DE102005054943A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Verfahren zur Herstellung eines Hohlprofils auf Basis eines vernetzten, Gelatine enthaltenden Materials sowie Implantate in Form von Hohlprofilen
DE102005054938A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Formkörper auf Basis eines vernetzten, Gelatine enthaltenden Materials, Verfahren zu deren Herstellung sowie deren Verwendung
DE102005054941A1 (de) 2005-11-17 2007-05-31 Gelita Ag Nervenleitschiene
DE102005054937A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Angiogenese förderndes Substrat
WO2007135915A1 (ja) * 2006-05-23 2007-11-29 Kirin Techno-System Company, Limited 表面検査装置
DE102006033168A1 (de) 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
DE102006033167A1 (de) * 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
GB2444323B (en) * 2006-11-30 2011-04-06 Ethicon Inc Protein sheet material
WO2008072379A1 (ja) * 2006-12-13 2008-06-19 Fujifilm Corporation 修飾された生体高分子の製造方法及び生体高分子の架橋方法
DE102007024239A1 (de) 2007-05-16 2008-11-20 Gelita Ag Angiogenese förderndes Substrat
DE102007024256A1 (de) 2007-05-16 2008-11-20 Gelita Ag Gefäßstent
DE102007051059B4 (de) 2007-10-18 2014-04-03 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen
JP5497449B2 (ja) * 2007-11-28 2014-05-21 富士フイルム株式会社 生体高分子およびポリペプチドの化学修飾方法
DE102008020197A1 (de) * 2008-04-15 2009-10-22 Gelita Ag Schnell benetzbares, Hydrokolloid enthaltendes Material, Verfahren zu dessen Herstellung sowie dessen Verwendung
CN104031393B (zh) * 2008-06-18 2017-08-01 生命连结有限公司 改进的交联组合物
DE102008054245A1 (de) * 2008-10-24 2010-04-29 Aesculap Ag Fixierungselement zum Fixieren von Gewebe und/oder Implantaten
DE102009018640A1 (de) * 2009-04-17 2010-10-21 Tetec Tissue Engineering Technologies Ag Implantat und therapeutische Zusammensetzung zur Behandlung von Schäden und/oder Erkrankungen im Bereich des menschlichen und/oder tierischen Stütz- und Bewegungsapparates
JP5483274B2 (ja) * 2009-08-07 2014-05-07 利江 土屋 軟骨用移植材
CA2782863A1 (en) 2009-12-22 2011-06-30 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
DE102011004239A1 (de) 2011-02-16 2012-08-16 Gelita Ag Verwendung eines medizinischen Implantats als Adhäsionsbarriere
EP2962703B1 (de) * 2013-02-27 2020-08-19 FUJIFILM Corporation Zellkonstrukt für zelltransplantation, biokompatibler polymerblock und verfahren zur herstellung davon
US9849217B2 (en) 2013-04-18 2017-12-26 Board Of Regents, The University Of Texas System Antimicrobial wraps for medical implants
JP6355959B2 (ja) * 2014-04-24 2018-07-11 国立大学法人京都工芸繊維大学 機能性架橋構造体及びその製造方法並びに医療材料
JP6434438B2 (ja) * 2016-03-31 2018-12-05 富士フイルム株式会社 ゼラチン成形体の製造方法
DE102016110089B4 (de) 2016-06-01 2020-02-06 Christine Konert Kapsel aus vernetzter Gelatine für die portionsweise Zubereitung eines Getränks und deren Verwendung
JP7041346B2 (ja) * 2018-02-28 2022-03-24 澁谷工業株式会社 ゼラチン支持体を用いた細胞培養方法
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
JP7303511B2 (ja) * 2019-02-18 2023-07-05 青葉化成株式会社 医療材料およびその製造方法
DE102020116722B4 (de) 2020-06-25 2023-12-14 Christian Klinger Mehrkomponentensystem zum Herstellen eines Materials, Material und Verfahren zum Herstellen eines solchen Materials
CN114099766B (zh) * 2020-09-01 2022-12-06 中科硅骨(东莞)医疗器械有限公司 改性明胶止血材料及其制备方法
CN112898591B (zh) * 2021-02-19 2022-06-21 杭州楠大环保科技有限公司 一种复合微生物制剂用载体及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
EP1053757A1 (de) * 1999-05-15 2000-11-22 Doris Weitzel-Kage Gewebekonstrukt für die Transplantationschirurgie
US20010031437A1 (en) * 2000-02-24 2001-10-18 Hiroshi Kawamoto Method of producing water-soluble chain-extended gelatin, gelatin produced by the method, and silver halide photographic light-sensitive material containing the gelatin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191329509A (en) * 1913-12-22 1914-07-09 Thomas Steele Improved Method of Manufacturing Artificial Tooth Fronts.
DE7135934U (de) * 1971-09-22 1971-12-16 Agfa Gevaert Ag Optische filter
DE2218009A1 (de) * 1972-04-14 1973-11-08 Agfa Gevaert Ag Verfahren zur haertung gelatinehaltiger schichten
GB1538075A (en) * 1975-03-24 1979-01-10 Champion Paper Co Ltd Formation of microcapsules by interfacial cross-linking and microcapsules produced thereby
US4264493A (en) * 1978-10-18 1981-04-28 Battista Orlando A Natural protein polymer hydrogels
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
DE3608158A1 (de) * 1986-03-12 1987-09-17 Braun Melsungen Ag Mit vernetzter gelatine impraegnierte gefaessprothese und verfahren zu ihrer herstellung
FR2597501B1 (fr) * 1986-04-18 1990-01-19 Merieux Inst Procede de fabrication de nappes de collagene, nappes obtenues et leurs applications
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4904554A (en) * 1988-03-21 1990-02-27 Hughes Aircraft Company Gas phase hardening of gelatin holograms
JP2511834B2 (ja) * 1990-09-27 1996-07-03 鐘紡株式会社 二層性ゼラチンシ―ト及びその製造方法
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
JPH0654899A (ja) * 1991-05-02 1994-03-01 Kanebo Ltd 二層性蛋白質シ−トの製造方法
JP2699260B2 (ja) * 1994-05-18 1998-01-19 和歌山県 ゼラチン樹脂の製造方法
US5834232A (en) * 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
TW528600B (en) * 1996-11-20 2003-04-21 Yasuhiko Shimizu Artificial neural canal
US7029838B2 (en) * 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
DE10135275A1 (de) * 2001-07-13 2003-01-30 Jotec Gmbh Implantat und Verfahren zu seiner Herstellung
DE10149392A1 (de) * 2001-09-27 2003-04-24 Aesculap Ag & Co Kg Implantat, insbesondere Gefäßprothese, und Verfahren zu seiner Herstellung
JP4295482B2 (ja) * 2002-08-08 2009-07-15 グンゼ株式会社 癒着防止材

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
EP1053757A1 (de) * 1999-05-15 2000-11-22 Doris Weitzel-Kage Gewebekonstrukt für die Transplantationschirurgie
US20010031437A1 (en) * 2000-02-24 2001-10-18 Hiroshi Kawamoto Method of producing water-soluble chain-extended gelatin, gelatin produced by the method, and silver halide photographic light-sensitive material containing the gelatin

Also Published As

Publication number Publication date
CR8427A (es) 2006-11-23
US20070077274A1 (en) 2007-04-05
BRPI0510782A (pt) 2007-11-20
WO2005111121A2 (de) 2005-11-24
DE102004024635A1 (de) 2005-12-08
EP1747247A2 (de) 2007-01-31
AU2005243474A1 (en) 2005-11-24
CA2558351A1 (en) 2005-11-24
EA200602031A1 (ru) 2007-08-31
JP2007537314A (ja) 2007-12-20
ZA200609115B (en) 2008-06-25
ECSP066989A (es) 2006-12-29
NO20065652L (no) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2005111121A3 (de) Verfahren zur herstellung von formkörpern auf basis von vernetzter gelatine
WO2005106090A3 (en) Preform produced by electrospinning, method for producting the same and use of such a preform
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
EA200900536A1 (ru) Способ получения хиральных 8-(3-аминопиперидин-1-ил) ксантинов
AU2003256654A1 (en) Hydrophobic surface treatment composition and method of making and using same
WO2007097949A3 (en) Method and apparatus for forming porous metal implants
DE602005017027D1 (de) Verfahren zur enzymatischen herstellung von (s)-3-cyano-5-methylhexansäure
WO2002051449A3 (en) Composition and process for bone growth and repair
WO2003106416A3 (en) CHEMICAL PROCESS
DE60333715D1 (de) Verfahren zur Herstellung funktioneller Substrate, die kolumnare Mikrosäulen aufweisen
WO2008075376A8 (en) Polymorphic forms of bortezomib and process for their preparation
WO2003003860A3 (en) Stabilized compositions and processes of their preparation
WO2004015132A3 (en) Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives
WO2008058236A3 (en) Methods for preparing cinacalcet hydrochloride
WO2004071466A3 (en) Manufacturing process for liposomal preparations
WO2007048115A3 (en) Method of using and producing tropoelastin and tropoelastin biomaterials
AU2003227743A1 (en) Method for the production of cellulose carbamate moulded bodies
WO2004087700A8 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
WO2005042057A3 (en) Methods and apparatus for intraluminal device
DE60332894D1 (de) Verfahren zur Herstellung eines immobilisierten Enzyms
WO2010025721A3 (de) Degradierbares implantat und verfahren zu seiner herstellung sowie deren verwendung
AU2003291302A1 (en) Method for treatment of premature ejaculation in humans
AU2003243055A1 (en) Method of preparing an aqueous meloxicam solution and aqueous solution thus produced
WO2006004774A3 (en) Laulimalide analogues as therapeutic agents
AU2003300018A1 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005745724

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 546906

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2005243474

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2005243474

Country of ref document: AU

Date of ref document: 20050512

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005243474

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/009868

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2558351

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007512103

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2006/09115

Country of ref document: ZA

Ref document number: 11555295

Country of ref document: US

Ref document number: 200609115

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 200602031

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 2005745724

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11555295

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0510782

Country of ref document: BR